Missouri Study to Explore Early Development (SEED) Follow-Up
Project Number5U01DD001289-03
Contact PI/Project LeaderFITZGERALD, ROBERT Other PIs
Awardee OrganizationWASHINGTON UNIVERSITY
Description
Abstract Text
Project Summary
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that impacts approximately 1.5% of
children in the United States. Individuals with ASD experience deficits in social communication or restricted
interests and repetitive behavior; but the severity and patterns vary greatly and convey lifelong impairment for
some. It is unclear how the presentation of ASD changes from early childhood into adolescence or adulthood.
The causes of ASD are also unknown, though substantial evidence supports the contribution of both genes
and environmental factors. These gaps in knowledge exist because US studies to date have lacked the
sample size, depth of data collection, or appropriate life course timing to address these questions. The Study
to Explore Early Development (SEED) is now able to address these prior limitations. SEED is a large case-
control study of children ages 2-5 years and their families, implemented across eight states over three phases.
SEED collected detailed data on children's core ASD symptoms, cognitive status, and presence of co-
occurring conditions in early childhood, along with extensive risk factors related to maternal health and the
perinatal environment as well as genomics. The SEED sample includes 2044 children with ASD, 1950 children
with non-ASD developmental disabilities (DD), and 2285 population control children (POP), making this the
largest etiologic study of ASD in the US. Recent ancillary studies - the SEED Teen Pilot and SEED COVID
studies -- will soon add data on adolescent health and the consequences of the pandemic, respectively, for
some SEED participants. The work proposed here, SEED Follow-up Studies (SEED FU), will maximize the
impact of extant SEED data through analyses that characterize ASD phenotypes and assess the potential
interplay between genetic and modifiable risk factors. SEED FU will also facilitate new data collection in
middle childhood, adolescence and early adulthood to characterize changes in ASD phenotype across
developmental stages, and the associated health, educational, and service needs across the early life course.
These data will further enable prospective analyses of associations between early life factors and later
childhood through early adulthood outcomes. Studying risk factors in relation to life course phenotypic
subgroups may also help elucidate etiologies previously masked in ASD case-control studies. The MO SEED
Team in combination with the SEED Network's collaborative infrastructure and extensive extant data
resources, will ensure the successful implementation of the SEED FU Study in Missouri and contribute to
success across the network. SEED is well-powered for making significant contributions to our understanding
of the complex autism phenotype and identifying factors associated with ASD risk in the population. The
knowledge gained by SEED FU will greatly advance our ability prevent adverse developmental outcomes and
to support individuals with ASD and their families to ensure optimal wellbeing through early adulthood.
Public Health Relevance Statement
Project Narrative
This study will shed light on a wide variety of genetic, prenatal, early-life and family factors that influence the
risk for autism spectrum disorder (ASD) and on differences and similarities in the behaviors, abilities, and
health of preschoolers with ASD. It will also provide insights into the experiences of adolescents with ASD as
they mature. By helping to explain the causes of ASD and how ASD affects children, youth and young adults,
this project will contribute to efforts to reduce the risk of ASD and improve the outcomes of affected children.
National Center on Birth Defects and Developmental Disabilities
CFDA Code
073
DUNS Number
068552207
UEI
L6NFUM28LQM5
Project Start Date
01-July-2021
Project End Date
30-June-2026
Budget Start Date
01-July-2023
Budget End Date
30-June-2024
Project Funding Information for 2023
Total Funding
$322,648
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2023
National Center on Birth Defects and Developmental Disabilities
$322,648
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U01DD001289-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01DD001289-03
Patents
No Patents information available for 5U01DD001289-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01DD001289-03
Clinical Studies
No Clinical Studies information available for 5U01DD001289-03
News and More
Related News Releases
No news release information available for 5U01DD001289-03
History
No Historical information available for 5U01DD001289-03
Similar Projects
No Similar Projects information available for 5U01DD001289-03